anti-TAA monoclonal antibody-chelator conjugate BAY3547922

An immunoconjugate comprised of a monoclonal antibody directed against an as of yet undisclosed tumor-associated antigen (TAA) conjugated to an as of yet undisclosed chelator. When bound to the radioisotope zirconium Zr 89 (Zr89), the monoclonal antibody moiety of anti-TAA monoclonal antibody-chelator conjugate BAY3547922 specifically targets and binds to the TAA expressed on tumor cells, which may allow the tracing of TAA-expressing tumor cells upon positron emission tomography/computed tomography (PET/CT).